KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Short-term Investments (2016 - 2025)

Supernus Pharmaceuticals (SUPN) has disclosed Short-term Investments for 14 consecutive years, with $180.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Short-term Investments fell 53.1% to $180.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $180.2 million, a 53.1% decrease, with the full-year FY2025 number at $180.2 million, down 53.1% from a year prior.
  • Short-term Investments was $180.2 million for Q4 2025 at Supernus Pharmaceuticals, up from $129.8 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $384.3 million in Q4 2024 to a low of $105.2 million in Q3 2023.
  • A 5-year average of $231.1 million and a median of $191.9 million in 2022 define the central range for Short-term Investments.
  • Peak YoY movement for Short-term Investments: skyrocketed 253.16% in 2024, then plummeted 65.07% in 2025.
  • Supernus Pharmaceuticals' Short-term Investments stood at $136.2 million in 2021, then skyrocketed by 170.26% to $368.2 million in 2022, then plummeted by 51.16% to $179.8 million in 2023, then skyrocketed by 113.7% to $384.3 million in 2024, then crashed by 53.1% to $180.2 million in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Short-term Investments are $180.2 million (Q4 2025), $129.8 million (Q3 2025), and $377.9 million (Q2 2025).